tirzepatide nejm #VisualAbstract: Improved Outcomes in Patients with Obstructive Sleep Apnea and Obesity New research providing further support

Other companion products make it effortless to choose foods aligned with the dietary goals of GLP patients, providing personalized recommendations based on factors like cultural preferences, lifestyle, and other dietary restrictions or preferences (such a gluten intolerance or vegetarianism)

rapid weight loss, 2

Administered once weekly, GLP-1 therapy injections have been shown to result in weight loss exceeding 50 pounds in as little as six months an attractive option for individuals looking to achieve substantial weight reduction efficiently

Aggregationinduced emission luminogens for in vivo molecular imaging and theranostics in cancer

Glucagon-like peptide-1 receptor agonists (GLP-1RAs), which were initially approved for the treatment of type 2 diabetes (T2D) and obesity, have cardiovascular benefits that extend beyond glycaemic control